Literature DB >> 30519940

Quantitative, Real-Time Measurements of Intracellular Target Engagement Using Energy Transfer.

Matthew B Robers1, James D Vasta2, Cesear R Corona3, Rachel Friedman Ohana2, Robin Hurst2, Manisha A Jhala4, Kenneth M Comess4, Keith V Wood2.   

Abstract

Intracellular target affinity and residence time are fundamental aspects of pharmacological mechanism (Lu and Tonge, Curr Opin Chem Biol 14:467-474, 2010). Although various robust biochemical approaches exist to measure these binding characteristics, analysis of compound binding with isolated targets may not accurately reflect engagement in the milieu of living cells. To realize the influence of cellular context, methods are needed that are capable of quantifying affinity and residence time in the presence of the intracellular factors that may impact target engagement. Bioluminescence resonance energy transfer (BRET) offers a solution for intracellular target engagement when quantitative metrics or kinetic analyses are required.

Keywords:  BRET; Intracellular affinity; NanoBRET(TM); Residence time; Target engagement

Mesh:

Substances:

Year:  2019        PMID: 30519940     DOI: 10.1007/978-1-4939-8891-4_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  A High-Throughput Method to Prioritize PROTAC Intracellular Target Engagement and Cell Permeability Using NanoBRET.

Authors:  James D Vasta; Cesear R Corona; Matthew B Robers
Journal:  Methods Mol Biol       Date:  2021

2.  Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance.

Authors:  Agatha Lyczek; Benedict-Tilman Berger; Aziz M Rangwala; YiTing Paung; Jessica Tom; Hannah Philipose; Jiaye Guo; Steven K Albanese; Matthew B Robers; Stefan Knapp; John D Chodera; Markus A Seeliger
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-16       Impact factor: 11.205

3.  Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells.

Authors:  Steffen Brunst; Julia Schönfeld; Peter Breunig; Luisa D Burgers; Murphy DeMeglio; Johanna H M Ehrler; Felix F Lillich; Lilia Weizel; Jasmin K Hefendehl; Robert Fürst; Ewgenij Proschak; Kerstin Hiesinger
Journal:  ACS Med Chem Lett       Date:  2022-06-14       Impact factor: 4.632

4.  Conformational control and regulation of the pseudokinase KSR via small molecule binding interactions.

Authors:  Arthur Chow; Zaigham M Khan; William M Marsiglia; Arvin C Dar
Journal:  Methods Enzymol       Date:  2022-04-25       Impact factor: 1.682

Review 5.  Targeted protein degradation as a powerful research tool in basic biology and drug target discovery.

Authors:  Tao Wu; Hojong Yoon; Yuan Xiong; Sarah E Dixon-Clarke; Radosław P Nowak; Eric S Fischer
Journal:  Nat Struct Mol Biol       Date:  2020-06-15       Impact factor: 15.369

6.  Equilibrium and Kinetic Measurements of Ligand Binding to HiBiT-tagged GPCRs on the Surface of Living Cells.

Authors:  Michelle E Boursier; Sergiy Levin; Robin Hurst; Rachel Friedman Ohana
Journal:  Bio Protoc       Date:  2020-12-20

7.  Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK.

Authors:  Michael Forster; Xiaojun Julia Liang; Martin Schröder; Stefan Gerstenecker; Apirat Chaikuad; Stefan Knapp; Stefan Laufer; Matthias Gehringer
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

8.  Quantifying CDK inhibitor selectivity in live cells.

Authors:  Carrow I Wells; James D Vasta; Cesear R Corona; Jennifer Wilkinson; Chad A Zimprich; Morgan R Ingold; Julie E Pickett; David H Drewry; Kathryn M Pugh; Marie K Schwinn; Byounghoon Brian Hwang; Hicham Zegzouti; Kilian V M Huber; Mei Cong; Poncho L Meisenheimer; Timothy M Willson; Matthew B Robers
Journal:  Nat Commun       Date:  2020-06-02       Impact factor: 14.919

9.  Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3.

Authors:  Martin Schröder; Panagis Filippakopoulos; Martin P Schwalm; Carla A Ferrer; David H Drewry; Stefan Knapp; Apirat Chaikuad
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

10.  Structural basis for the action of the drug trametinib at KSR-bound MEK.

Authors:  Zaigham M Khan; Alexander M Real; William M Marsiglia; Arthur Chow; Mary E Duffy; Jayasudhan R Yerabolu; Alex P Scopton; Arvin C Dar
Journal:  Nature       Date:  2020-09-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.